Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Reckitt Benckiser Group
(OTCPK:RBGPF)
Intraday
$55.112
0.586
[1.07%]
Get Report
Watch
Perks
Buy
Compare Brokers
$55.112
0.586
[1.07%]
At close: Apr 26
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Reckitt Benckiser Group Stock (OTC:RBGPF)
Reckitt Benckiser Group Stock (OTC: RBGPF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, March 15, 2024
What's Going On With Abbott Laboratories Stock On Friday?
Vandana Singh
-
Mar 15, 2024, 1:48PM
Thursday, February 29, 2024
Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
Benzinga Neuro
-
Feb 29, 2024, 2:54AM
Tuesday, September 12, 2023
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
Vandana Singh
-
Sep 12, 2023, 4:06PM
Wednesday, May 24, 2023
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
Vandana Singh
-
May 24, 2023, 8:39AM
Friday, December 02, 2022
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
Anusuya Lahiri
-
Dec 2, 2022, 6:53AM
Thursday, September 01, 2022
Dettol Maker Reckitt Benckiser's CEO Steps Down
Shivani Kumaresan
-
Sep 1, 2022, 7:58AM
Thursday, August 11, 2022
Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
Vandana Singh
-
Aug 11, 2022, 7:40AM
Wednesday, July 27, 2022
Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage
Vandana Singh
-
Jul 27, 2022, 7:37AM
Wednesday, May 25, 2022
More Companies Join Race To Ease US Baby Formula Supply Crunch
Vandana Singh
-
May 25, 2022, 7:26AM
Friday, May 20, 2022
Danone Scales Up Baby Formula Shipments To US To Combat Shortage: Reuters
Vandana Singh
-
May 20, 2022, 7:47AM
Friday, April 29, 2022
Morning Brief: Top Financial Stories Dominating on Friday, April 29
Akanksha Bakshi
-
Apr 29, 2022, 7:52AM
Reckitt Benckiser Hikes Prices To Compensate For Falling Demand: FT
Shivani Kumaresan
-
Apr 29, 2022, 7:37AM
Thursday, October 26, 2017
Wall Street's M&A Chatter From October 25: Sprint-T-Mobile, Trade Desk, Pfizer, Dynegy
Benzinga
-
Oct 26, 2017, 7:35AM
Monday, July 17, 2017
Wall Street's M&A Chatter From July 14-16: Dominion Diamond, Unilever-Hormel-Reckitt, H&E Equipment-Neff, Mobileye-Intel
Benzinga
-
Jul 17, 2017, 7:02AM
Thursday, May 01, 2014
Benzinga's M&A Chatter for Thursday May 1, 2014
Benzinga
-
May 1, 2014, 6:51PM
Wednesday, April 30, 2014
Reckitt Benckiser Confirms it is No Longer in Talks with Merck Regarding Bid for Consumer Health Business
Benzinga
-
Apr 30, 2014, 12:54PM
Monday, April 28, 2014
Benzinga's M&A Chatter for Monday April 28, 2014
Benzinga
-
Apr 28, 2014, 6:50PM
Reckitt Benckiser Confirms Talks With Merck Regarding Bid for Consumer Health Business, Bayer Also Rumored Bidder
Benzinga
-
Apr 28, 2014, 12:11PM
Sunday, April 27, 2014
Benzinga's Weekend M&A Chatter
Benzinga
-
Apr 27, 2014, 8:21PM
Saturday, April 26, 2014
Reuters Reports Merck in Talks to Sell Consumer Health Unit to Bayer, Reckitt Benckiser for Approximately $14B, According to Sources
Benzinga
-
Apr 26, 2014, 2:41PM
Friday, November 22, 2013
Reuters Reports Reckitt Benckiser Hires Morgan Stanley to Advise on Options for Pharma Unit
Benzinga
-
Nov 22, 2013, 1:29PM
Wednesday, September 11, 2013
Reckitt Benckiser CEO Rakesh Kapoor Says Company has Ability to do Large M&A -Reuters
Benzinga
-
Sep 11, 2013, 10:30AM
Monday, August 05, 2013
Is Procter & Gamble a Strategic Bet?
Benzinga
-
Aug 5, 2013, 9:16AM
Thursday, November 22, 2012
Benzinga's M&A Chatter for Wednesday November 21, 2012
Benzinga
-
Nov 22, 2012, 12:06PM
